NCT07075471View on ClinicalTrials.gov

Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Tenosynovial Giant Cell Tumor
Trial Locations (1)

28401

RECRUITING

Synexus Clinical Research, US INC, Wilmington

Sponsors
All Listed Sponsors
lead

Deciphera Pharmaceuticals, LLC

INDUSTRY